about
Carotid endarterectomy for asymptomatic carotid stenosisEffects of aspirin plus extended-release dipyridamole versus clopidogrel and telmisartan on disability and cognitive function after recurrent stroke in patients with ischaemic stroke in the Prevention Regimen for Effectively Avoiding Second StrokesAspirin and extended-release dipyridamole versus clopidogrel for recurrent strokeEffect of treatment delay, age, and stroke severity on the effects of intravenous thrombolysis with alteplase for acute ischaemic stroke: a meta-analysis of individual patient data from randomised trialsTwenty-Year History of the Evolution of Stroke Thrombolysis With Intravenous Alteplase to Reduce Long-Term DisabilityEvaluation of combination therapy in animal models of cerebral ischemiaTrial application of a Model of Resource Utilization, Costs, and Outcomes for Stroke (MORUCOS) to assist priority setting in strokeWarfarin for atrial fibrillation: the end of an era?Should the MATCH results be extrapolated to all stroke patients and affect ongoing trials evaluating clopidogrel plus aspirin?Stroke units, tissue plasminogen activator, aspirin and neuroprotection: which stroke intervention could provide the greatest community benefit?Aspirin therapy should be first line: probably, but watch this spaceAspirin after intracerebral haemorrhage: probably safer than we thoughtTreating the acute stroke patient as an emergency: current practices and future opportunities.Aortic arch atheroma and the risk of strokeNeuroprotection and thrombolysis: combination therapy in acute ischaemic strokeA randomized trial of tenecteplase versus alteplase for acute ischemic strokeConfusing stroke terminology: watershed or borderzone infarction?StrokePerfusion computed tomography to assist decision making for stroke thrombolysisStroke: working toward a prioritized world agendaStroke: working toward a prioritized world agendaStroke: working toward a prioritized world agenda1,026 experimental treatments in acute strokeAcute Stroke Imaging Research Roadmap II.Echoplanar magnetic resonance imaging in acute stroke.Extrastriate visual cortex reorganizes despite sequential bilateral occipital stroke: implications for vision recovery.Salvaging the ischaemic penumbra: more than just reperfusion?Neuroimaging, the ischaemic penumbra, and selection of patients for acute stroke therapy.Time is Penumbra: imaging, selection and outcome. The Johann jacob wepfer award 2014.Pooling of animal experimental data reveals influence of study design and publication bias.Imaging the ischaemic penumbra.Where will the next generation of stroke treatments come from?Readmissions after stroke: linked data from the Australian Stroke Clinical Registry and hospital databases.Selection of thrombolytic therapy beyond 3 h using magnetic resonance imaging.A collaborative sequential meta-analysis of individual patient data from randomized trials of endovascular therapy and tPA vs. tPA alone for acute ischemic stroke: ThRombEctomy And tPA (TREAT) analysis: statistical analysis plan for a sequential metSafety and Efficacy of Solitaire Stent Thrombectomy: Individual Patient Data Meta-Analysis of Randomized Trials.Endovascular thrombectomy after large-vessel ischaemic stroke: a meta-analysis of individual patient data from five randomised trials.Proof-of-principle phase II MRI studies in stroke: sample size estimates from dichotomous and continuous data.Risk of intracerebral haemorrhage with alteplase after acute ischaemic stroke: a secondary analysis of an individual patient data meta-analysis.Acute stroke imaging research roadmap.
P50
Q24245826-4ABFBD07-8E7D-4CF3-9BAC-93007770B992Q24645205-64CF51D9-47F1-4A2C-A209-B5B159625410Q24646522-3DF6D154-4770-406B-8A08-8734FB59953FQ26823902-F4CA5C35-ABDE-40D6-8F2B-7FF3627F400DQ26853103-1152BBAC-518A-413E-B022-D667EB0A2CFEQ27025781-F108E8A8-30C1-4B08-B409-1E2931AC449BQ28167910-A0D2B0A6-84EE-42CC-8F4A-E4B5488FBAD6Q28168341-39A00047-7B08-4BE2-B066-EFC588571D8EQ28171067-4DE52A7A-B404-41BB-B998-97B1D623D2C5Q28189131-D97BEF2E-65EA-43F5-9E66-AB6CD7F233C4Q28193543-6C4C062E-C187-4D4A-8394-25CA9F739B97Q28195789-4541C638-5F64-4F06-9D0F-BF6F54758C27Q28196628-FB321AB7-8E22-499C-9AC7-6324B11F2D17Q28199139-840ECA2D-CC1E-4654-B356-C3AA9D60E0CDQ28199814-1D54F9B7-37A0-4873-98BB-A9A86D7F652DQ28262393-7886C919-FC19-4171-86B1-F5B2EAD75902Q28266871-21D3E838-9E81-4A96-8947-E4ACF6B66713Q28279570-E6233056-3FE4-4E02-93F1-36A1B5729881Q28607578-7A2C610A-A79E-4AA5-B084-12376B1E58A2Q28677503-BC69ECF6-25E3-4335-A223-13F2C7D9B928Q28677657-120C7402-3198-4BDD-B253-7F6D52F5F78DQ28742458-88AE2808-5622-46B1-8A64-865034305579Q29615509-B034DE78-E789-4D21-9081-F23FC93B6829Q30411115-11A3B1D4-70AB-42FE-BF46-ECC0C2241E9EQ30597307-228256C3-5C4F-48B0-91B5-AFA2D78A07B4Q30644777-0FE1D02A-4D59-4312-A536-4482EA33EF90Q30682992-5D402719-754E-4A3F-88FF-9A069AE2D29FQ30810278-1678BD4D-61C6-450A-9CDE-4EC8E0F286CEQ30852108-CA4E5F96-2744-4F07-BEE1-C8AE3DF43902Q30918723-CB2EBA1A-AED8-41A3-8224-0402E10EE055Q30922333-2BC2F446-BA6E-4AB3-8B92-1DE3A207FE69Q30979218-5957E40E-A469-413D-B719-9E2BD5CADE6FQ30980441-7072A02A-831D-49D0-BA91-E400C5E8B0D0Q30980758-3DB8893F-91FB-4C20-A2CD-B956D8A10DC5Q30992330-7AF0FCC9-47ED-47AD-92C0-C9EB414A8191Q31047368-B56943BB-3CB8-43D3-B044-BE8C2A99B8D8Q31048053-3C833022-15AC-462B-90F7-9E621BB252F5Q31056850-663ED563-4749-4BEC-B9D5-24237981494DQ31107456-05FA10BF-7224-48F5-B8D3-53BD7BF52F2FQ31152222-7B99D420-73CE-4F5A-939F-67D295C266AE
P50
subject
description
hulumtues
@sq
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Geoffrey A. Donnan
@ast
Geoffrey A. Donnan
@en
Geoffrey A. Donnan
@es
Geoffrey A. Donnan
@nl
Geoffrey A. Donnan
@sl
type
label
Geoffrey A. Donnan
@ast
Geoffrey A. Donnan
@en
Geoffrey A. Donnan
@es
Geoffrey A. Donnan
@nl
Geoffrey A. Donnan
@sl
altLabel
Geoffrey Donnan
@en
prefLabel
Geoffrey A. Donnan
@ast
Geoffrey A. Donnan
@en
Geoffrey A. Donnan
@es
Geoffrey A. Donnan
@nl
Geoffrey A. Donnan
@sl
P106
P1153
35375703700
P21
P31
P496
0000-0001-6324-3403